The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Investigation

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI44745PMID 21633165PMCID PMC3223826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation.

  2011cited by this paper
• LIF independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease

  2010cited by this paper
• Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805

  2010cited by this paper
• Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.

  2010cited by this paper
• The therapeutic promise of the cancer stem cell concept.

  2010cited by this paper
• Targeting breast cancer stem cells.

  2010cited by this paper
• Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft

  2010cited by this paper
• Aspirin intake and survival after breast cancer.

  2010cited by this paper
• Tumor heterogeneity: causes and consequences.

  2010cited by this paper
• Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

  2010cited by this paper
• CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.

  2010cited by this paper
• Functional analysis of OMICs data and small molecule compounds in an integrated "knowledge-based" platform.

  2009cited by this paper
• The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

  2009cited by this paper
• Inflammation and cancer: IL-6 and STAT3 complete the link.

  2009cited by this paper
• STAT3 as a central regulator of tumor metastases.

  2009cited by this paper
• IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasis

  2009cited by this paper
• The Increasing Complexity of the Cancer Stem Cell Paradigm

  2009cited by this paper
• Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

  2009cited by this paper
• gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• Targeting breast cancer stem cells.

  2009cited by this paper
• CXCR2 antagonists for the treatment of pulmonary disease.

  2009cited by this paper
• Reciprocal Effects of STAT5 and STAT3 in Breast Cancer

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

  2009cited by this paper
• JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies.

  2008cited by this paper
• The CD44+/CD24- phenotype is enriched in basal-like breast tumors

  2008cited by this paper
• Triple-Negative Breast Cancer: Risk Factors to Potential Targets

  2008cited by this paper
• The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

  2008cited by this paper
• Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth

  2008cited by this paper
• Regulation of in situ to invasive breast carcinoma transition.

  2008cited by this paper
• Osteopontin: regulation in tumor metastasis

  2008cited by this paper
• Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells*

  2008cited by this paper
• Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling

  2008cited by this paper
• Novel role of CXCR2 in regulation of gamma-secretase activity.

  2008cited by this paper
• JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials

  2008cited by this paper
• Cell type-specific DNA methylation patterns in the human breast

  2008cited by this paper
• Highly parallel identification of essential genes in cancer cells

  2008cited by this paper
• Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

  2008cited by this paper
• Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

  2008cited by this paper
• Significance of interleukin-6 (IL-6) in breast cancer (review)

  2007cited by this paper
• CXC chemokines located in the 4q21 region are up-regulated in breast cancer.

  2007cited by this paper
• IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.

  2007cited by this paper
• Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis

  2007cited by this paper
• Molecular definition of breast tumor heterogeneity.

  2007cited by this paper
• Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer

  2007cited by this paper
• Genome-scale loss-of-function screening with a lentiviral RNAi library

  2006cited by this paper
• Menadione-induced Reactive Oxygen Species Generation via Redox Cycling Promotes Apoptosis of Murine Pancreatic Acinar Cells*

  2006cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• Cancer as an evolutionary and ecological process

  2006cited by this paper
• Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective.

  2006cited by this paper
• Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.

  2006cited by this paper
• Anti-interleukin-6 receptor antibody therapy in rheumatic diseases.

  2006cited by this paper
• Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

  2006cited by this paper
• Targeting of CD44 eradicates human acute myeloid leukemic stem cells

  2006cited by this paper
• Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer.

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

  2005cited by this paper
• Purification and characterization of recombinant human prostacyclin synthase.

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Autocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines*

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells

  1999cited by this paper
• B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.

  1997cited by this paper

• Biomimetic liposomes synergize with high-intensity focused ultrasound to induce ferroptosis in tumors

  2026cites this paper
• Research progress on vasculogenic mimicry in colorectal cancer: mechanisms and therapeutic

  2026cites this paper
• Adipocyte-driven STAT3-ANGPT2-PTGIS axis promotes cutaneous metastasis in breast cancer and represents a targetable pathway.

  2026cites this paper
• The relationship between CXC chemokines and cellular senescence: from mechanisms to therapy

  2026cites this paper
• The Roles of STAT3 and STAT5 in Breast Cancer

  2025cites this paper
• Identification of Natural Inhibitors Targeting MMP-9 via Network Pharmacology and Advanced Molecular Modeling Approaches

  2025cites this paper
• Molecular mechanisms and signaling pathways related to brain metastasis in breast cancer

  2025cites this paper
• The dual role of autophagy in cancer stem cells: implications for tumor progression and therapy resistance

  2025cites this paper
• Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance

  2025cites this paper
• JAK2 Inhibition Augments the Anti-Proliferation Effects by AKT and MEK Inhibition in Triple-Negative Breast Cancer Cells

  2025cites this paper
• Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation.

  2025cites this paper
• Bridging Pathogens: Epstein‐Barr Virus and Helicobacter pylori in Gastric Cancer Stem Cell Regulation

  2025cites this paper
• Lineage Tracing and Single-Cell RNA Sequencing Reveal a Common Transcriptional State in Breast Cancer Tumor–Initiating Cells Characterized by IFN/STAT1 Activity

  2025cites this paper
• Translational drugs targeting cancer stem cells in triple-negative breast cancer

  2025cites this paper
• Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles

  2025cites this paper
• Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids

  2025cites this paper
• Potential applications of PFKFB in cancer treatment strategies.

  2025cites this paper
• CD44 Marks Dormant Tumor Cells After HER2 Inhibition in Breast Cancer Cells

  2025cites this paper
• Cellular Plasticity and Treatment Resistance in Breast Cancer: A Literature Review

  2025cites this paper
• Exposure to Brominated Flame Retardants During Pregnancy and Lactation Increases the Prevalence of Breast Lesions and Cancer-Associated Pathways in Sprague-Dawley Rats.

  2025cites this paper
• Unveiling the link between chronic inflammation and cancer

  2025cites this paper
• Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors

  2025cites this paper
• Navigating the Molecular Signaling: Deciphering Cancer Stem Cell Self-Renewal Pathways

  2025cites this paper
• Formosanin C inhibits triple-negative breast cancer progression by suppressing the phosphorylation of STAT3 and the polarization of M2 macrophages

  2025cites this paper
• Non-coding RNAs as key regulators of epithelial-mesenchymal transition in breast cancer

  2025cites this paper
• MCPIP1 Controls Hybrid EMT and Tumor Stemness via the IL6/JAK2/STAT3 Axis in Pancreatic Cancer

  2025cites this paper
• B-cell lymphoma 6 in breast cancer: molecular mechanisms and clinical significance

  2025cites this paper
• Kurarinone targets JAK2‐STAT3 signaling in colon cancer‐stem‐like cells

  2024cites this paper
• Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors

  2024cites this paper
• Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma

  2024cites this paper
• Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 (Review)

  2024cites this paper
• Molecular changes in breast cancer induced by radiation therapy.

  2024cites this paper
• TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer

  2024cites this paper
• Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway

  2024cites this paper
• Serine/Threonine kinase 16 phosphorylates STAT3 and confers a JAK2-Inhibition resistance phenotype in triple-negative breast cancer.

  2024cites this paper
• Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells

  2024cites this paper
• AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells

  2024cites this paper
• Aberrantly Expressed Mitochondrial Lipid Kinase, AGK Activates JAK2-Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy.

  2024cites this paper
• ALDH1 subtype-specific inhibitor targets key cancerous epithelial cell populations in aggressive subtypes of breast cancer

  2024cites this paper
• Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation

  2024cites this paper
• Activation of Mammary Epithelial and Stromal Fibroblasts upon Exposure to Escherichia coli Metabolites

  2024cites this paper
• Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models

  2024cites this paper
• Autophagy as a Therapeutic Target in Breast Tumors: The Cancer stem cell perspective

  2024cites this paper
• A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity

  2024cites this paper
• Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer

  2024cites this paper
• Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer

  2024cites this paper
• Updates on altered signaling pathways in tumor drug resistance

  2024cites this paper
• BP1003 Decreases STAT3 Expression and Its Pro-Tumorigenic Functions in Solid Tumors and the Tumor Microenvironment

  2024cites this paper
• Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4+T cell activation in breast cancer

  2024cites this paper
• The convergence of genomic medicine and translational omics in transforming breast cancer patient care

  2024cites this paper
• Acovenosigenin A β-glucoside mediates JAK2-STAT3 signaling pathway by targeting GP130 in A549 and H460 cells based on integrative analysis of transcriptome and proteome and biological verification.

  2024cites this paper
• Identifying the mechanism of polysaccharopeptide against breast cancer based on network pharmacology and experimental verification

  2024cites this paper
• C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer

  2024influential citation
• STAT3 Regulates the Redox Profile in MDA-MB-231 Breast Cancer Cells

  2024cites this paper
• Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24neg cells in the locally advanced and metastatic breast cancer

  2024cites this paper
• Dual Inhibition of the TrkA and JAK2 pathways using Entrectinib and Pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers.

  2024cites this paper
• CXCL3: A key player in tumor microenvironment and inflammatory diseases.

  2024cites this paper
• Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions.

  2024cites this paper
• Type II mode of JAK2 inhibition and destabilization are potential therapeutic approaches against the ruxolitinib resistance driven myeloproliferative neoplasms

  2024cites this paper
• Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment

  2024cites this paper
• The Role of Salivary Vascular Endothelial Growth Factor A, Cytokines, and Amino Acids in Immunomodulation and Angiogenesis in Breast Cancer

  2024cites this paper
• Exploring the Influence of miR-597-5p on the Tumor Stem Cell Characteristics of Gastric Cancer Cells Through the STAT3/NF-κB Signaling Pathway

  2023cites this paper
• The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling

  2023cites this paper
• HOXB7 induces STAT3‐mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells

  2023cites this paper
• A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance

  2023cites this paper
• Targeting Breast Cancer Stem Cells through Retinoids: A New Hope for Treatment.

  2023cites this paper
• Domperidone Exerts Antitumor Activity in Triple-Negative Breast Cancer Cells by Modulating Reactive Oxygen Species and JAK/STAT3 Signaling

  2023cites this paper
• Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer

  2023cites this paper
• Post-translational modification of CDK1–STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties

  2023cites this paper
• Validating the role of PTGIS gene in colorectal cancer by bioinformatics analysis and in vitro experiments

  2023cites this paper
• Effects of Hyaluronan on Breast Cancer Aggressiveness

  2023cites this paper
• Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches

  2023cites this paper
• Cancer Cachexia and breast cancer stem cell signalling - A crosstalk of signalling molecules.

  2023cites this paper
• Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer

  2023cites this paper
• The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy.

  2023cites this paper
• Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: a computational study of gene regulatory pathways using Boolean networks

  2023cites this paper
• TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma

  2023cites this paper
• Identification of novel inhibitors from Urtica spp against TNBC targeting JAK2 receptor for breast cancer therapy

  2023cites this paper
• β, β-Dimethylacrylshikonin potentiates paclitaxel activity, suppresses immune evasion and triple negative breast cancer progression via STAT3Y705 phosphorylation inhibition based on network pharmacology and transcriptomics analysis.

  2023cites this paper
• Metabolites and Bioactivity of the Marine Xestospongia Sponges (Porifera, Demospongiae, Haplosclerida) of Southeast Asian Waters

  2023cites this paper
• Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.

  2023cites this paper
• Differential functional coupling in Gp130-JAK complexes expands the plasticity of the interleukin-6 signaling axis

  2023cites this paper
• IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy.

  2023cites this paper
• Inflammatory auxo-action in the stem cell division theory of cancer

  2023cites this paper
• Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective

  2023cites this paper
• Loss of miR‐6844 alters stemness/self‐renewal and cancer hallmark(s) markers through CD44‐JAK2‐STAT3 signaling axis in breast cancer stem‐like cells

  2023cites this paper
• Hyperglycemia induces PFKFB3 overexpression and promotes malignant phenotype of breast cancer through RAS/MAPK activation

  2023cites this paper
• Current Therapeutic Approaches and Promising Perspectives of Using Bioengineered Peptides in Fighting Chemoresistance in Triple-Negative Breast Cancer.

  2023cites this paper
• Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs

  2023cites this paper
• Variable Intrinsic Expression of Immunoregulatory Biomarkers in Breast Cancer Cell Lines, Mammospheres, and Co-Cultures

  2023cites this paper
• Nanomedicines: intervention in inflammatory pathways of cancer

  2023cites this paper
• PDJ amplicon in triple negative breast cancer

  2023cites this paper
• MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells

  2023cites this paper
• The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer.

  2023cites this paper
• Ethacridine Regulation of JAK/STAT/ERK Signaling Pathway in Colon Cancer Cells SW620: In vitro Approach

  2023cites this paper
• The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future

  2023cites this paper
• Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance

  2023cites this paper
• Therapeutic vulnerabilities of cancer stem cells and effects of natural products.

  2023cites this paper
• Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens

  2022cites this paper
• DNA minicircles as novel STAT3 decoy oligodeoxynucleotides endowed with anticancer activity in triple-negative breast cancer

  2022cites this paper